{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:40:58Z","timestamp":1762144858100},"reference-count":18,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.dld.2012.04.001","type":"journal-article","created":{"date-parts":[[2012,5,11]],"date-time":"2012-05-11T05:30:15Z","timestamp":1336714215000},"page":"788-792","source":"Crossref","is-referenced-by-count":27,"title":["Safety and effectiveness of sorafenib in patients with hepatocellular carcinoma in clinical practice"],"prefix":"10.1016","volume":"44","author":[{"given":"Giovan Giuseppe","family":"Di Costanzo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"Tortora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Iodice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso Galeota","family":"Lanza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Lampasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Tartaglione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco Paolo","family":"Picciotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvana","family":"Mattera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2012.04.001_bib0005","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"year":"2007","series-title":"Global cancer facts & figures 2007","author":"Garcia","key":"10.1016\/j.dld.2012.04.001_bib0010"},{"key":"10.1016\/j.dld.2012.04.001_bib0015","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(03)14964-1","article-title":"Hepatocellular carcinoma","volume":"362","author":"Llovet","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2012.04.001_bib0020","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/hep.21176","article-title":"The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients","volume":"43","author":"Sangiovanni","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2012.04.001_bib0025","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.20933","article-title":"Management of hepatocellular carcinoma","volume":"42","author":"Bruix","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2012.04.001_bib0030","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","article-title":"Clinical management of hepatocellular carcinoma: conclusions of the Barcelona-2000 EASL Conference","volume":"35","author":"Bruix","year":"2001","journal-title":"J Hepatol"},{"issue":"359","key":"10.1016\/j.dld.2012.04.001_bib0035","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2012.04.001_bib0040","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.dld.2012.04.001_bib0045","unstructured":"European Medicines Agency. Sorafenib (Nexavar): summary of product characteristics [online]. Available from URL: http:\/\/www.emea.europa.eu\/humandocs\/PDFs\/EPAR\/nexavar\/H-690-PI-en.pdf."},{"issue":"Suppl.","key":"10.1016\/j.dld.2012.04.001_bib0050","article-title":"GIDEON (Global Investigation of Therapeutic DEcisions in Hepatocellular Carcinoma [HCC]nd Of Its Treatment With SorafeNib) Second Interim Analysis in >1500 patients: clinical findings in patients with liver dysfunction","volume":"29","author":"Marrero","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.dld.2012.04.001_bib0055","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","article-title":"Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver","volume":"35","author":"Bruix","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2012.04.001_bib0060","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-2007-1007122","article-title":"Prognosis of hepatocellular carcinoma: the BCLC staging classification","volume":"19","author":"Llovet","year":"1999","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.dld.2012.04.001_bib0065","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.dld.2012.04.001_bib0070","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/02841860701765675","article-title":"Risk of hand-foot skin reaction with sorafenib: a systematic review and metaanalysis","volume":"47","author":"Chu","year":"2008","journal-title":"Acta Oncol"},{"key":"10.1016\/j.dld.2012.04.001_bib0075","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1634\/theoncologist.2009-0143","article-title":"Early skin toxicity as a predictive factor for tumor control in hepatocellular carcinoma patients treated with sorafenib","volume":"15","author":"Vincenzi","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.dld.2012.04.001_bib0080","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S1470-2045(09)70222-0","article-title":"Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials","volume":"10","author":"Je","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.dld.2012.04.001_bib0085","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S1470-2045(09)70366-3","article-title":"Risk of bleeding not increased by sorafenib or sunitinib","volume":"11","author":"Minor","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.dld.2012.04.001_bib0090","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/lt.21083","article-title":"A randomized study comparing ligation with propranolol for primary prophylaxis of variceal bleeding in candidates for liver transplantation","volume":"13","author":"Norberto","year":"2007","journal-title":"Liver Transpl"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865812001405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865812001405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T14:55:33Z","timestamp":1561733733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865812001405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":18,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S1590865812001405"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2012.04.001","relation":{},"ISSN":["1590-8658"],"issn-type":[{"type":"print","value":"1590-8658"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}